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Mutations in the endoglin gene (ENG) are responsible for∼50%of all caseswith hereditary
hemorrhagic telangiectasia (HHT). Because of the absence of effective treatments for
HHT symptoms, studies aimed at identifying novel biological functions of endoglin which
could serve as therapeutic targets of the disease are needed. Endoglin is an endothelial
membrane protein, whose most studied function has been its role as an auxiliary
receptor in the TGF-β receptor complex. However, several lines of evidence suggest the
involvement of endoglin inTGF-β-independent functions. Endoglin displays, within its zona
pellucida domain, an RGD motif, which is a prototypic sequence involved in integrin-
based interactions with other proteins. Indeed, we have recently described a novel role
for endothelial endoglin in leukocyte trafﬁcking and extravasation via its interaction with
leukocyte integrins. In addition, functional, as well as protein and gene expression analysis
have shown that ectopic endoglin represses the synthesis of several members of the
integrin family and modulates integrin-mediated cell adhesions. This review focuses on
the tight link between endoglin and integrins and how the role of endothelial endoglin
in integrin-dependent cell adhesion processes can provide a better understanding of the
pathogenic mechanisms leading to vascular lesions in endoglin haploinsufﬁcient HHT1
patients.
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ENDOGLIN INVOLVEMENT IN HEREDITARY HEMORRHAGIC
TELANGIECTASIA
Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-
Weber syndrome is a vascular hereditary autosomal dominant
disease associated with epistaxis, telangiectasias, gastrointesti-
nal hemorrhages, and arteriovenous malformations in lung,
liver, and brain (Shovlin, 2010; McDonald et al., 2011). The
ﬁrst gene identiﬁed as being involved in HHT was ENDOGLIN
(ENG) that maps to chromosome 9 (Fernández-Ruiz et al., 1993;
McAllister et al., 1994), representing between 39 and 59% of the
total HHT population, a frequency that depends on the geo-
graphic location. Several 100 different pathogenic mutations
have been described in ENG giving rise to the HHT1 sub-
type (Abdalla and Letarte, 2006). Haploinsufﬁciency is accepted
as the underlying mechanism of HHT1 pathogenicity, but the
ﬁne cellular and molecular machinery involved remains to be
elucidated.
ENDOGLIN STRUCTURE, EXPRESSION, AND FUNCTION
Human endoglin is a type I integral membrane protein with
a large extracellular (EC) domain (561 amino acids), a sin-
gle hydrophobic transmembrane (TM) domain, and a short
cytosolic tail (Figure 1A). Endoglin is a glycosylated protein
expressed as a 180-kDa disulﬁde-linked homodimer in endothe-
lial cells (Gougos and Letarte, 1990). The predominant expression
of endoglin in endothelial cells suggests that these are the tar-
get cells in HHT, where endoglin haploinsufﬁciency reveals its
pathogenicity. Structurally, endoglin belongs to the zona pel-
lucida (ZP) family of proteins that share a juxtamembrane ZP
domain of 260 amino acid residues in their EC region (Llorca
et al., 2007). This ZP domain encodes an RGD tripeptide that is
a prototypic member of a family of motifs involved in integrin-
based interactions with EC matrix and certain cell surface proteins
(Takada et al., 2007). Recently, it has been demonstrated that
endothelial endoglin interacts with leukocyte integrin α5β1 via
its RGD motif, suggesting a regulatory role for endoglin in
transendothelial leukocyte trafﬁcking (Rossi et al., 2013). The
RGD motif is present in endoglin from primates, while func-
tionally related RGD-like motifs are found in endoglin from
rodents and other mammals, stressing the physiological impor-
tance and high conservation of this motif (Gougos and Letarte,
1990; Rossi et al., 2013). Next to the ZP domain is the orphan
domain, which is located in the NH2-terminus of the protein
(Llorca et al., 2007). The orphan domain is involved in the binding
to members of the TGF-β superfamily (activin, TGF-β, and BMP
families) in accordance with the role of endoglin as an auxiliary
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FIGURE 1 | Structure and cell adhesion function of endoglin. (A)
Structural representation of endoglin. Endoglin is a type I membrane
protein with a large extracellular (EC) domain that contains a zona
pellucida (ZP) domain in the juxtamembrane region and an
NH2-terminal orphan domain. The ZP domain encodes an Arg-Gly-Asp
(RGD) tripeptide that is involved in integrin binding, whereas de
orphan domain is involved in binding to members of the TGF-β
superfamily. Endoglin forms dimers and the corresponding monomers
are disulphide linked (S-S). The cytoplasmic (CYT) domain can be
phosphorylated (P) at Ser/Thr/Tyr residues. The transmembrane (TM),
and EC domains of the protein are indicated. The scheme is not to
scale. (B) Role of endothelial endoglin in leukocyte adhesion and
transmigration. A schematic diagram shows a hypothetical model for
leukocyte transmigration through the vessel endothelium. In an
inﬂammatory focus, different soluble factors are released, including the
chemokine CXCL12, leading to activation and endoglin-dependent
extravasation of leukocytes. The transmigration process of the
leukocyte involves the binding of CXCL12 to its receptor CXCR4,
which in turn activates β1 integrins. Once activated, β1 integrin binds
to the RGD motif of endoglin present on the endothelial cell surface,
allowing the extravasation and migration of leukocytes to the
inﬂammatory site.
TGF-β receptor (Alt et al., 2012). Thus, endoglin modulates the
endothelial response to TGF-β-related ligands, including cell pro-
liferation, apoptosis, vascular remodeling, angiogenesis, wound
healing, or ﬁbrosis (López-Novoa and Bernabeu, 2010). Of note,
most of ENG mutations associated with HHT1 map to the EC
domain, suggesting that the biological function of this domain
is critical for the disease (Bernabeu et al., 2010). The cytosolic
domain of endoglin is phosphorylated at Ser/Thr/Tyr residues
and it can be targeted by serine/threonine (Lastres et al., 1994)
and tyrosine (Pan et al., 2014) kinases. It has been shown that
the endoglin phosphorylation status can inﬂuence its subcellular
localization (Koleva et al., 2006) and degradation (Pan et al., 2014).
The cytoplasmic domainof endoglin also regulates actin cytoskele-
tal organization, microtubule-based transport machinery, and cell
migration (Ray et al., 2010; Romero et al., 2010), through its spe-
ciﬁc binding to different cytosolic proteins (López-Novoa and
Bernabeu, 2010).
ENDOGLIN IN INTEGRIN-MEDIATED SIGNALING AND
CELLULAR FUNCTION
Integrins are ubiquitous cell surface receptors involved in cell–cell
and cell–EC matrix interactions (Takada et al., 2007) that play a
relevant role in vascular biology (Plow et al., 2014). The functional
role of endothelial endoglin as a counter-receptor for leuko-
cytes’ integrins has been recently reported (Rossi et al., 2013).
Interestingly, inﬂammatory leukocyte recruitment, which involves
integrin-mediated cell–cell interactions, is critical for proper vas-
cular remodeling. Several animal models of inﬂammation and
vascular repair have shown that endoglin haploinsufﬁciency leads
to an abnormal leukocyte inﬁltration and function that depends
on the target organ or the triggering stimulus (van Laake et al.,
2006; Jerkic et al., 2010; Rossi et al., 2013; Ardelean et al., 2014;
Peter et al., 2014; Shen et al., 2014). Thus, an inﬂammation model
of dextran sodium sulfate (DSS)-induced chronic colitis revealed
more leukocyte inﬁltration in the gut and a more severe colitis
phenotype in endoglin heterozygous (Eng+/−) mice relative to
control animals (Jerkic et al., 2010; Ardelean et al., 2014; Peter
et al., 2014). After myocardial infarction, a greater deterioration
in cardiac function was observed in Eng+/− compared to con-
trol mice, although host inﬂammatory leukocyte numbers in the
infarct zone were similar; however, defects in vessel formation
and heart function in Eng+/− mice were rescued by injection
of leukocytes from healthy human donors, but not by leuko-
cytes from HHT1 patients (van Laake et al., 2006). Moreover,
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upon permanent distal middle cerebral artery occlusion, Eng+/−
mice showed larger infarct/atrophic volumes associated with
fewer inﬁltrating macrophages, suggesting that endoglin deﬁ-
ciency impairs brain injury recovery by impairing macrophage
homing, delaying inﬂammation resolution, and reducing angio-
genesis (Shen et al., 2014). Furthermore, decreased inﬂammation-
induced leukocyte trafﬁcking to peritoneum and lungs was found
in Eng+/− mice treated with the inﬂammatory agents carrageenan
or lipopolysaccharide (LPS), respectively (Rossi et al., 2013). The
impaired leukocyte trafﬁcking was observed for neutrophils, lym-
phocytes,monocytes, and basophiles. The nature of thismigratory
process was assessed using in vitro cell adhesion and transmi-
gration studies. Leukocytes treated with the chemokine CXCL12,
an integrin activator, strongly adhered to endoglin-coated plates
and to endoglin-expressing endothelial cells. Similarly, leukocyte
transmigration through adherent cell monolayers was dependent
on the presence of endoglin. Both, endoglin-dependent cellu-
lar adhesion and transmigration processes involved the leukocyte
integrin α5β1 via the endoglin RGD motif (Rossi et al., 2013).
Based on these results, a hypothetical model is illustrated in
Figure 1B.
Additional lines of evidence support a tight link between inte-
grins and endoglin functions: (i) on overexpression of endoglin,
ﬁbroblasts tend to form clusters that involve α5β1 integrin and are
inhibited by coating the culture plates with an RGD-containing
fragment of ﬁbronectin (Guerrero-Esteo et al., 1999); (ii) analysis
of integrin-rich sites of focal adhesion, isolated with RGD-labeled
microspheres, shows that endoglin regulates cell migration and
focal adhesion composition via interaction through its cytoplas-
mic domain with the protein zyxin present in focal adhesion sites
(Conley et al., 2004); (iii) binding of human pathogenic bacte-
ria to the carcinoembryonic antigen (CEA) in epithelial cells,
triggers de novo expression of endoglin, which, in turn changes
focal adhesion composition, activating β1 integrins and induc-
ing a dramatic increase in the ECM-binding capacity of the cells
(Muenzner et al., 2010); (iv) endoglin mediates ﬁbronectin/α5β1
integrin and TGF-β pathway crosstalk in endothelial cells via the
internalization of the cell surface α5β1 integrin/endoglin complex
(Tian et al., 2012); and (v) protein and gene expression analysis
have shown that ectopic endoglin represses the synthesis of several
members of the integrin family and modulates integrin-related
biological functions, including cell adhesion and transmigration
(Aristorena et al., 2014; Blanco et al., 2014). Moreover, endoglin is
able to antagonize the integrins’ downstream MAPK pathway, by
inhibiting ERK signaling and altering the subcellular distribution
of activated ERK (Lee and Blobe, 2007; Santibanez et al., 2010).
Taken together, these data strongly suggest a close physical and
functional associationbetween endoglin and integrins andprompt
the question of whether the adhesion role of endothelial endoglin,
as a counter-receptor for leukocytes’ integrins, is involved in the
HHT pathogenesis.
IS THE ROLE OF ENDOGLIN IN CELL–CELL ADHESION
INVOLVED IN HHT PATHOGENESIS?
A common feature in HHT patients is the presence of vascu-
lar lesions (telangiectasias and arteriovenous malformations) that
lead to a loss of the intervening capillary network that connects
the arteriole with the venule (Braverman et al., 1990). How-
ever, it remains unclear why the vascular lesions appear only at
distinct sites within certain organs, rather than being present
throughout the body and in all organs/tissues. To explain this
paradox, the need for a trigger such as inﬂammation, vascu-
lar injury, angiogenic stimuli, or ischemia has been postulated
(Park et al., 2009; López-Novoa and Bernabeu, 2010; Choi et al.,
2014). In HHT1, this trigger would synergize with endoglin
haploinsufﬁciency to generate the vascular lesion (Lopez-Novoa,
2012; Choi et al., 2014). Interestingly, those stimuli are usu-
ally associated with the upregulated expression of endoglin in
endothelial cells and an inﬂammatory cell inﬁltrate (Torsney
et al., 2002; López-Novoa and Bernabeu, 2010), suggesting the
need of both, endoglin function and leukocyte inﬁltration, in
the vascular repair/remodeling process. Indeed, it has been
reported that endoglin plays a crucial role in leukocyte-mediated
vascular repair (van Laake et al., 2006). Of note, HHT skin
telangiectasias show a perivascular mononuclear cell inﬁltrate,
including lymphocytes and monocytes/macrophages (Braverman
et al., 1990). This is in agreement with the leukocyte inﬁl-
tration occurring during angiogenesis and vascular remodeling
(Jaipersad et al., 2014). Therefore, it can be hypothesized that
the function of endothelial endoglin as an adhesion counter-
receptor for leukocyte’s integrins is involved inHHT1pathogenesis
(Figure 2). According to this hypothetical model, in healthy
FIGURE 2 | Hypothetical model for the generation of arteriovenous
malformations in HHT. In healthy subjects, the capillary network
subjected to an inﬂammatory stimulus is inﬁltrated with leukocytes that
contribute to the vascular repair/remodeling. As a consequence the
capillary network is restored. In HHT1 patients, endoglin haploinsufﬁciency
impairs leukocyte adhesion/transmigration, leading to a defective vascular
repair/remodeling. As a consequence, the capillary network gradually
disappears and only a preferential vessel remains that eventually becomes
the arteriovenous shunt.
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subjects the capillary network subjected to an inﬂammatory
stimulus is inﬁltrated with leukocytes that contribute to the
vascular repair/remodeling. By contrast, in HHT1 patients
endoglin haploinsufﬁciency impairs leukocyte inﬁltration, lead-
ing to a defective vascular repair/remodeling. As a consequence,
the capillary network would disappear and only a preferen-
tial vessel remains that eventually becomes the arterio-venous
shunt.
CONCLUSION AND PERSPECTIVES
Anovel role for endothelial endoglin as a cellular adhesion receptor
has been reported. Here, we postulate a model attempting to relate
the cell adhesion function of endoglin to the pathobiology of HHT.
In the HHT1 setting, endoglin protein levels may not reach the
minimum threshold to achieve the optimal function in leukocyte
adhesion mediated by integrins. This endoglin haploinsufﬁciency
alters leukocyte transmigration and may synergize with a trigger
such as inﬂammation to generate the vascular lesion. The func-
tion of endoglin as an adhesion counter-receptor for integrins may
help to understand the pathogenicity in HHT and may be a poten-
tial therapeutic target in HHT. Modulators of endoglin/integrin
cell adhesion are putative drugs to be tested. In addition to the
endothelial cell–leukocyte adhesion, it would be of interest to
investigate whether the adhesion of endothelial cells with mural
cells also involves the endoglin/integrin interaction.
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